{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T09:48:03Z","timestamp":1794044883957,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T00:00:00Z","timestamp":1680739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s12264-023-01054-5","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T12:04:27Z","timestamp":1680782667000},"page":"1411-1425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Dynamics of Dopamine D2 Receptor-Expressing Striatal Neurons and the Downstream Circuit Underlying L-Dopa-Induced Dyskinesia in Rats"],"prefix":"10.1007","volume":"39","author":[{"given":"Kuncheng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3820-7598","authenticated-orcid":false,"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,6]]},"reference":[{"key":"1054_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S1474-4422(03)00529-5","volume":"2","author":"AD Lawrence","year":"2003","unstructured":"Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson\u2019s disease: Reward systems gone awry? Lancet Neurol 2003, 2: 595\u2013604.","journal-title":"Lancet Neurol"},{"key":"1054_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(10)70218-0","volume":"9","author":"P Calabresi","year":"2010","unstructured":"Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B. Levodopa-induced dyskinesias in patients with Parkinson\u2019s disease: Filling the bench-to-bedside gap. Lancet Neurol 2010, 9: 1106\u20131117.","journal-title":"Lancet Neurol"},{"key":"1054_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnana.2018.00113","volume":"12","author":"NLG Del Rey","year":"2018","unstructured":"Del Rey NLG, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fern\u00e1ndez-Santiago R, Monje MHG. Advances in Parkinson\u2019s disease: 200 years later. Front Neuroanat 2018, 12: 113.","journal-title":"Front Neuroanat"},{"key":"1054_CR4","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1111\/ene.13466","volume":"24","author":"S Perez-Lloret","year":"2017","unstructured":"Perez-Lloret S, Negre-Pages L, Damier P, Delval A, Derkinderen P, Dest\u00e9e A, et al. L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: The COPARK survey. Eur J Neurol 2017, 24: 1532\u20131538.","journal-title":"Eur J Neurol"},{"key":"1054_CR5","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1007\/s12264-021-00749-x","volume":"37","author":"S Li","year":"2021","unstructured":"Li S, Jia C, Li T, Le W. Hot topics in recent Parkinson\u2019s disease research: Where we are and where we should go. Neurosci Bull 2021, 37: 1735\u20131744.","journal-title":"Neurosci Bull"},{"key":"1054_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/mds.26947","volume":"32","author":"LF Hern\u00e1ndez","year":"2017","unstructured":"Hern\u00e1ndez LF, Castela I, Ruiz-DeDiego I, Obeso JA, Moratalla R. Striatal activation by optogenetics induces dyskinesias in the 6-hydroxydopamine rat model of Parkinson disease. Mov Disord 2017, 32: 530\u2013537.","journal-title":"Mov Disord"},{"key":"1054_CR7","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/mds.26955","volume":"32","author":"XA Perez","year":"2017","unstructured":"Perez XA, Zhang D, Bordia T, Quik M. Striatal D1 medium spiny neuron activation induces dyskinesias in parkinsonian mice. Mov Disord 2017, 32: 538\u2013548.","journal-title":"Mov Disord"},{"key":"1054_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.neuron.2018.01.017","volume":"97","author":"AE Girasole","year":"2018","unstructured":"Girasole AE, Lum MY, Nathaniel D, Bair-Marshall CJ, Guenthner CJ, Luo L, et al. A subpopulation of striatal neurons mediates levodopa-induced dyskinesia. Neuron 2018, 97: 787\u2013795.","journal-title":"Neuron"},{"key":"1054_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fnana.2011.00051","volume":"5","author":"MG Murer","year":"2011","unstructured":"Murer MG, Moratalla R. Striatal signaling in L-DOPA-induced dyskinesia: Common mechanisms with drug abuse and long term memory involving D1 dopamine receptor stimulation. Front Neuroanat 2011, 5: 51.","journal-title":"Front Neuroanat"},{"key":"1054_CR10","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1111\/febs.15908","volume":"289","author":"S Cataldi","year":"2022","unstructured":"Cataldi S, Stanley AT, Miniaci MC, Sulzer D. Interpreting the role of the striatum during multiple phases of motor learning. FEBS J 2022, 289: 2263\u20132281.","journal-title":"FEBS J"},{"key":"1054_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0301-0082(99)00067-2","volume":"62","author":"F Blandini","year":"2000","unstructured":"Blandini F, Nappi G, Tassorelli C, Martignoni E. Functional changes of the basal ganglia circuitry in Parkinson\u2019s disease. Prog Neurobiol 2000, 62: 63\u201388.","journal-title":"Prog Neurobiol"},{"key":"1054_CR12","doi-asserted-by":"publisher","first-page":"V1","DOI":"10.1007\/PL00007778","volume":"247","author":"K Nakano","year":"2000","unstructured":"Nakano K, Kayahara T, Tsutsumi T, Ushiro H. Neural circuits and functional organization of the striatum. J Neurol 2000, 247: V1\u2013V15.","journal-title":"J Neurol"},{"key":"1054_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/35086062","volume":"2","author":"E Bezard","year":"2001","unstructured":"Bezard E, Brotchie JM, Gross CE. Pathophysiology of levodopa-induced dyskinesia: Potential for new therapies. Nat Rev Neurosci 2001, 2: 577\u2013588.","journal-title":"Nat Rev Neurosci"},{"key":"1054_CR14","doi-asserted-by":"publisher","first-page":"783893","DOI":"10.3389\/fnagi.2022.783893","volume":"14","author":"S Gao","year":"2022","unstructured":"Gao S, Gao R, Yao L, Feng J, Liu W, Zhou Y, et al. Striatal D1 dopamine neuronal population dynamics in a rat model of levodopa-induced dyskinesia. Front Aging Neurosci 2022, 14: 783893.","journal-title":"Front Aging Neurosci"},{"key":"1054_CR15","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1016\/j.celrep.2018.05.059","volume":"23","author":"MB Ryan","year":"2018","unstructured":"Ryan MB, Bair-Marshall C, Nelson AB. Aberrant striatal activity in Parkinsonism and levodopa-induced dyskinesia. Cell Rep 2018, 23: 3438-3446.e5.","journal-title":"Cell Rep"},{"key":"1054_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41586-018-0090-6","volume":"557","author":"JG Parker","year":"2018","unstructured":"Parker JG, Marshall JD, Ahanonu B, Wu YW, Kim TH, Grewe BF, et al. Diametric neural ensemble dynamics in parkinsonian and dyskinetic states. Nature 2018, 557: 177\u2013182.","journal-title":"Nature"},{"key":"1054_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1472-8206.1995.tb00518.x","volume":"9","author":"PJ Blanchet","year":"1995","unstructured":"Blanchet PJ, Gomez-Mancilla B, Di Paolo T, B\u00e9dard PJ. Is striatal dopaminergic receptor imbalance responsible for levodopa-induced dyskinesia? Fundam Clin Pharmacol 1995, 9: 434\u2013442.","journal-title":"Fundam Clin Pharmacol"},{"key":"1054_CR18","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","volume":"342","author":"O Rascol","year":"2000","unstructured":"Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson\u2019s disease who were treated with ropinirole or levodopa. N Engl J Med 2000, 342: 1484\u20131491.","journal-title":"N Engl J Med"},{"key":"1054_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2165\/00003495-199855001-00004","volume":"55","author":"UK Rinne","year":"1998","unstructured":"Rinne UK, Bracco F, Chouza C, Dupont E, Gershanik O, Marti Masso JF, et al. Early treatment of Parkinson\u2019s disease with cabergoline delays the onset of motor complications. Drugs 1998, 55: 23\u201330.","journal-title":"Drugs"},{"key":"1054_CR20","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1523\/JNEUROSCI.1614-20.2022","volume":"42","author":"AB Nelson","year":"2022","unstructured":"Nelson AB, Girasole AE, Lee HY, Pt\u00e1\u010dek LJ, Kreitzer AC. Striatal indirect pathway dysfunction underlies motor deficits in a mouse model of paroxysmal dyskinesia. J Neurosci 2022, 42: 2835\u20132848.","journal-title":"J Neurosci"},{"key":"1054_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1172\/JCI90132","volume":"127","author":"C Alcacer","year":"2017","unstructured":"Alcacer C, Andreoli L, Sebastianutto I, Jakobsson J, Fieblinger T, Cenci MA. Chemogenetic stimulation of striatal projection neurons modulates responses to Parkinson\u2019s disease therapy. J Clin Invest 2017, 127: 720\u2013734.","journal-title":"J Clin Invest"},{"key":"1054_CR22","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.biopsych.2009.04.025","volume":"66","author":"S Darmopil","year":"2009","unstructured":"Darmopil S, Mart\u00edn AB, De Diego IR, Ares S, Moratalla R. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation. Biol Psychiatry 2009, 66: 603\u2013613.","journal-title":"Biol Psychiatry"},{"key":"1054_CR23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1007\/s00429-018-01824-2","volume":"224","author":"Q Yu","year":"2019","unstructured":"Yu Q, Liu YZ, Zhu YB, Wang YY, Li Q, Yin DM. Genetic labeling reveals temporal and spatial expression pattern of D2 dopamine receptor in rat forebrain. Brain Struct Funct 2019, 224: 1035\u20131049.","journal-title":"Brain Struct Funct"},{"key":"1054_CR24","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jnr.23439","volume":"92","author":"Y Wang","year":"2014","unstructured":"Wang Y, Wang HS, Wang T, Huang C, Liu J. L-DOPA-induced dyskinesia in a rat model of Parkinson\u2019s disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum. J Neurosci Res 2014, 92: 1733\u20131745.","journal-title":"J Neurosci Res"},{"key":"1054_CR25","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/j.1471-4159.2009.06556.x","volume":"112","author":"HS Lindgren","year":"2010","unstructured":"Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson\u2019s disease: Temporal and quantitative relationship to the expression of dyskinesia. J Neurochem 2010, 112: 1465\u20131476.","journal-title":"J Neurochem"},{"key":"1054_CR26","volume-title":"The Rat Brain in Stereotaxic Coordinates","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Watson C (2004) The Rat Brain in Stereotaxic Coordinates, 5th edn Academic Press, San Diego.","edition":"5"},{"key":"1054_CR27","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1038\/s41467-019-10715-x","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang Y, Kim J, Schmit MB, Cho TS, Fang C, Cai H. A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding. Nat Commun 2019, 10: 2769.","journal-title":"Nat Commun"},{"key":"1054_CR28","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1006\/nbdi.2002.0499","volume":"10","author":"C Winkler","year":"2002","unstructured":"Winkler C, Kirik D, Bj\u00f6rklund A, Cenci MA. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of Parkinson\u2019s disease: Relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis 2002, 10: 165\u2013186.","journal-title":"Neurobiol Dis"},{"key":"1054_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nmeth.3770","volume":"13","author":"CK Kim","year":"2016","unstructured":"Kim CK, Yang SJ, Pichamoorthy N, Young NP, Kauvar I, Jennings JH, et al. Simultaneous fast measurement of circuit dynamics at multiple sites across the mammalian brain. Nat Methods 2016, 13: 325\u2013328.","journal-title":"Nat Methods"},{"key":"1054_CR30","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.cell.2014.05.017","volume":"157","author":"LA Gunaydin","year":"2014","unstructured":"Gunaydin LA, Grosenick L, Finkelstein JC, Kauvar IV, Fenno LE, Adhikari A, et al. Natural neural projection dynamics underlying social behavior. Cell 2014, 157: 1535\u20131551.","journal-title":"Cell"},{"key":"1054_CR31","doi-asserted-by":"publisher","first-page":"173093","DOI":"10.1016\/j.pbb.2020.173093","volume":"201","author":"CA Bruno","year":"2021","unstructured":"Bruno CA, O\u2019Brien C, Bryant S, Mejaes JI, Estrin DJ, Pizzano C, et al. pMAT: An open-source software suite for the analysis of fiber photometry data. Pharmacol Biochem Behav 2021, 201: 173093.","journal-title":"Pharmacol Biochem Behav"},{"key":"1054_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41586-020-2731-9","volume":"586","author":"S Vesuna","year":"2020","unstructured":"Vesuna S, Kauvar IV, Richman E, Gore F, Oskotsky T, Sava-Segal C, et al. Deep posteromedial cortical rhythm in dissociation. Nature 2020, 586: 87\u201394.","journal-title":"Nature"},{"key":"1054_CR33","doi-asserted-by":"publisher","first-page":"10503","DOI":"10.1038\/ncomms10503","volume":"7","author":"Y Li","year":"2016","unstructured":"Li Y, Zhong W, Wang D, Feng Q, Liu Z, Zhou J, et al. Serotonin neurons in the dorsal raphe nucleus encode reward signals. Nat Commun 2016, 7: 10503.","journal-title":"Nat Commun"},{"key":"1054_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11068-008-9027-6","volume":"36","author":"V Gradinaru","year":"2008","unstructured":"Gradinaru V, Thompson KR, Deisseroth K. eNpHR: A Natronomonas halorhodopsin enhanced for optogenetic applications. Brain Cell Bio 2008, 36: 129\u2013139.","journal-title":"Brain Cell Bio"},{"key":"1054_CR35","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.neuron.2017.02.033","volume":"93","author":"K Lee","year":"2017","unstructured":"Lee K, Holley SM, Shobe JL, Chong NC, Cepeda C, Levine MS, et al. Parvalbumin interneurons modulate striatal output and enhance performance during associative learning. Neuron 2017, 93: 1451\u20131463.","journal-title":"Neuron"},{"key":"1054_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1369-1600.2012.00479.x","volume":"18","author":"MT Stefanik","year":"2013","unstructured":"Stefanik MT, Moussawi K, Kupchik YM, Smith KC, Miller RL, Huff ML, et al. Optogenetic inhibition of cocaine seeking in rats. Addict Biol 2013, 18: 50\u201353.","journal-title":"Addict Biol"},{"key":"1054_CR37","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: An open-source platform for biological-image analysis. Nat Methods 2012, 9: 676\u2013682.","journal-title":"Nat Methods"},{"key":"1054_CR38","doi-asserted-by":"publisher","first-page":"7583","DOI":"10.1523\/JNEUROSCI.4932-12.2013","volume":"33","author":"H Sano","year":"2013","unstructured":"Sano H, Chiken S, Hikida T, Kobayashi K, Nambu A. Signals through the striatopallidal indirect pathway stop movements by phasic excitation in the substantia nigra. J Neurosci 2013, 33: 7583\u20137594.","journal-title":"J Neurosci"},{"key":"1054_CR39","doi-asserted-by":"publisher","first-page":"105429","DOI":"10.1016\/j.nbd.2021.105429","volume":"157","author":"L Andreoli","year":"2021","unstructured":"Andreoli L, Abbaszadeh M, Cao X, Cenci MA. Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism. Neurobiol Dis 2021, 157: 105429.","journal-title":"Neurobiol Dis"},{"key":"1054_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0014-4886(92)90125-A","volume":"117","author":"B Gomez-Mancilla","year":"1992","unstructured":"Gomez-Mancilla B, B\u00e9dard PJ. Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys. Exp Neurol 1992, 117: 185\u2013188.","journal-title":"Exp Neurol"},{"key":"1054_CR41","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1046\/j.1440-1681.2002.03677.x","volume":"29","author":"C Cavallotti","year":"2002","unstructured":"Cavallotti C, Nuti F, Bruzzone P, Mancone M. Age-related changes in dopamine D2 receptors in rat heart and coronary vessels. Clin Exp Pharmacol Physiol 2002, 29: 412\u2013418.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1054_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0028-3908(96)00100-1","volume":"35","author":"M Jaber","year":"1996","unstructured":"Jaber M, Robinson SW, Missale C, Caron MG. Dopamine receptors and brain function. Neuropharmacology 1996, 35: 1503\u20131519.","journal-title":"Neuropharmacology"},{"key":"1054_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","volume":"282","author":"CP Ford","year":"2014","unstructured":"Ford CP. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 2014, 282: 13\u201322.","journal-title":"Neuroscience"},{"key":"1054_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/0006-8993(94)91511-3","volume":"667","author":"R Arai","year":"1994","unstructured":"Arai R, Karasawa N, Geffard M, Nagatsu T, Nagatsu I. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase. Brain Res 1994, 667: 295\u2013299.","journal-title":"Brain Res"},{"key":"1054_CR45","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.nbd.2007.08.010","volume":"29","author":"K Buck","year":"2008","unstructured":"Buck K, Ferger B. Intrastriatal inhibition of aromatic amino acid decarboxylase prevents l-DOPA-induced dyskinesia: A bilateral reverse in vivo microdialysis study in 6-hydroxydopamine lesioned rats. Neurobiol Dis 2008, 29: 210\u2013220.","journal-title":"Neurobiol Dis"},{"key":"1054_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nn1040","volume":"6","author":"B Picconi","year":"2003","unstructured":"Picconi B, Centonze D, H\u00e5kansson K, Bernardi G, Greengard P, Fisone G, et al. Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia. Nat Neurosci 2003, 6: 501\u2013506.","journal-title":"Nat Neurosci"},{"key":"1054_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnana.2011.00055","volume":"5","author":"E Roze","year":"2011","unstructured":"Roze E, Cahill E, Martin E, Bonnet C, Vanhoutte P, Betuing S, et al. Huntington\u2019s disease and striatal signaling. Front Neuroanat 2011, 5: 55.","journal-title":"Front Neuroanat"},{"key":"1054_CR48","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1126\/science.aan2475","volume":"357","author":"JL Gomez","year":"2017","unstructured":"Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, et al. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 2017, 357: 503\u2013507.","journal-title":"Science"},{"key":"1054_CR49","doi-asserted-by":"publisher","first-page":"135432","DOI":"10.1016\/j.neulet.2020.135432","volume":"739","author":"FH Tran","year":"2020","unstructured":"Tran FH, Spears SL, Ahn KJ, Eisch AJ, Yun S. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice? Neurosci Lett 2020, 739: 135432.","journal-title":"Neurosci Lett"},{"key":"1054_CR50","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1146\/annurev-neuro-061010-113817","volume":"34","author":"L Fenno","year":"2011","unstructured":"Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci 2011, 34: 389\u2013412.","journal-title":"Annu Rev Neurosci"},{"key":"1054_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2017.04.011","volume":"294","author":"M Alam","year":"2017","unstructured":"Alam M, Rumpel R, Jin X, von Wrangel C, Tschirner SK, Krauss JK, et al. Altered somatosensory cortex neuronal activity in a rat model of Parkinson\u2019s disease and levodopa-induced dyskinesias. Exp Neurol 2017, 294: 19\u201331.","journal-title":"Exp Neurol"},{"key":"1054_CR52","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1093\/brain\/awl103","volume":"129","author":"F Alonso-Frech","year":"2006","unstructured":"Alonso-Frech F, Zamarbide I, Alegre M, Rodr\u00edguez-Oroz MC, Guridi J, Manrique M, et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson\u2019s disease. Brain 2006, 129: 1748\u20131757.","journal-title":"Brain"},{"key":"1054_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.brs.2013.09.001","volume":"7","author":"M Alam","year":"2014","unstructured":"Alam M, Capelle HH, Schwabe K, Krauss JK. Effect of deep brain stimulation on levodopa-induced dyskinesias and striatal oscillatory local field potentials in a rat model of Parkinson\u2019s disease. Brain Stimul 2014, 7: 13\u201320.","journal-title":"Brain Stimul"},{"key":"1054_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S0006-8993(03)03165-2","volume":"986","author":"AA Alcantara","year":"2003","unstructured":"Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML. Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Res 2003, 986: 22\u201329.","journal-title":"Brain Res"},{"key":"1054_CR55","doi-asserted-by":"publisher","first-page":"5472","DOI":"10.1523\/JNEUROSCI.1720-15.2016","volume":"36","author":"KE Glajch","year":"2016","unstructured":"Glajch KE, Kelver DA, Hegeman DJ, Cui Q, Xenias HS, Augustine EC, et al. Npas1+ pallidal neurons target striatal projection neurons. J Neurosci 2016, 36: 5472\u20135488.","journal-title":"J Neurosci"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-023-01054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-023-01054-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-023-01054-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T13:14:57Z","timestamp":1693314897000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-023-01054-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,6]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["1054"],"URL":"https:\/\/doi.org\/10.1007\/s12264-023-01054-5","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,6]]},"assertion":[{"value":"5 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}